Home › Funds › Index Venture Life Associates VI Ltd › CNTA
Index Venture Life Associates VI Ltd position in CNTA
CENTESSA PHARMACEUTICALS PLC
Index Venture Life Associates VI Ltd reported holding 9,961,789 shares of CNTA (CENTESSA PHARMACEUTICALS PLC) in its Q1 2026 13F filing — a position valued at US$395.7M, representing 100.00% of its reported portfolio and ranking #1 among its reported holdings. Index Venture Life Associates VI Ltd has disclosed CNTA holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Index Venture Life Associates VI Ltd's CNTA position evolved
Index Venture Life Associates VI Ltd first disclosed a stake in CNTA in Q4 2024 at 9,961,789 shares (US$166.9M). The position peaked in Q1 2026 at 9,961,789 shares, worth US$395.7M. Across 6 filings, Index Venture Life Associates VI Ltd held the position steady without any share-count change. The most recent filing (Q1 2026) shows 9,961,789 shares valued at US$395.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 9.96M | $166.86M | New |
| Q1 2025 | 9.96M | $143.25M | Hold |
| Q2 2025 | 9.96M | $130.90M | Hold |
| Q3 2025 | 9.96M | $241.57M | Hold |
| Q4 2025 | 9.96M | $249.14M | Hold |
| Q1 2026 | 9.96M | $395.68M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CNTA and 13F data
CNTA (CENTESSA PHARMACEUTICALS PLC) is a company whose sector is not yet classified in our data. 1 other funds we track also report a position in CNTA. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Index Venture Life Associates VI Ltd
FAQ
How long has Index Venture Life Associates VI Ltd held CNTA?
Index Venture Life Associates VI Ltd has disclosed CNTA holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
What is Index Venture Life Associates VI Ltd's current position in CNTA?
As of Q1 2026, Index Venture Life Associates VI Ltd holds 9.96M shares of CNTA (CENTESSA PHARMACEUTICALS PLC), valued at $395.68M, representing 100.00% of its reported portfolio and ranking #1.
Has Index Venture Life Associates VI Ltd been buying or selling CNTA?
In the latest 13F filing (Q1 2026), Index Venture Life Associates VI Ltd held unchanged its position in CNTA. The position peaked in Q1 2026 at 9.96M shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.